Efficiency Through Innovation
Colloidal Gold Detection Platform.
- The most advanced and highly developed technology platform available today, designed to deliver exceptional performance and innovation.
- User-friendly, whether for self-testing or point-of-care applications, to process the sample and interpret the results.
- Extensive range of applications, encompassing the detection of acute infectious diseases or drug abuse, making it a versatile tool for various diagnostic needs. Its adaptability ensures reliable performance in diverse settings, whether for medical diagnostics or substance monitoring.
Solutions
SARS-CoV-2 / Influenza A/B Antigen Rapid Self-Test Kit
Australian Register of Therapeutic Goods (ARTG No.:) 399270
One Step Test for SARS-CoV-2 / Influenza A/B is intended for the qualitative detection of SARS-CoV-2 antigens in human saliva samples. This test is used for individuals suspected of COVID-19 within the first seven days of the onset symptoms; such as headache, fever, cough, sore throat, loss of the sense of smell or taste shortness of breath, muscle pain. Meanwhile the test can also be applied for individuals without symptoms. Results are for the identification of SARS-CoV-2 antigen.
This test is used for self-test.
